IN8bio, Inc. (INAB)
NASDAQ: INAB · Real-Time Price · USD
1.440
+0.020 (1.41%)
At close: Jul 6, 2026, 4:00 PM EDT
1.430
-0.010 (-0.69%)
After-hours: Jul 6, 2026, 6:00 PM EDT
IN8bio Market Cap
IN8bio has a market cap or net worth of $14.18 million as of July 6, 2026. Its market cap has increased by 93.29% in one year.
Market Cap
14.18M
Enterprise Value
-5.41M
1-Year Change
93.29%
Ranking
Category
Stock Price
$1.44
Market Cap Chart
Since the IPO on July 30, 2021, IN8bio's market cap has decreased from $187.55M to $14.18M, a decrease of -92.44%. That is a compound annual growth rate of -40.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 6, 2026 | 14.18M | -37.92% |
| Dec 31, 2025 | 22.84M | 22.52% |
| Dec 31, 2024 | 18.64M | -68.76% |
| Dec 29, 2023 | 59.67M | 5.43% |
| Dec 30, 2022 | 56.60M | -31.25% |
| Dec 31, 2021 | 82.33M | -56.10% |
| Jul 30, 2021 | 187.55M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CalciMedica | 15.25M |
| Passage Bio | 15.01M |
| BioVie | 14.71M |
| Cyclerion Therapeutics | 14.55M |
| Lunai Bioworks | 14.51M |
| Cocrystal Pharma | 14.34M |
| Moleculin Biotech | 14.09M |
| Lexaria Bioscience | 13.88M |